Longitudinal efficacy and toxicity of SARS-CoV-2 vaccination in cancer patients treated with immunotherapy

Despite more than 2 years having elapsed since the onset of SARS-CoV-2 pandemic, a level of hesitation around increased SARS-CoV-2 vaccine toxicity in cancer patients receiving immunotherapy (IO) remains. This hesitation stems from the idea that IO agents could elicit an overwhelming immune stimulat...

Descripción completa

Detalles Bibliográficos
Autores principales: Spiliopoulou, Pavlina, Janse van Rensburg, Helena J., Avery, Lisa, Kulasingam, Vathany, Razak, Albiruni, Bedard, Philippe, Hansen, Aaron, Chruscinski, Andrzej, Wang, Ben, Kulikova, Maria, Chen, Rachel, Speers, Vanessa, Nguyen, Alisa, Lee, Jasmine, Coburn, Bryan, Spreafico, Anna, Siu, Lillian L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9853486/
https://www.ncbi.nlm.nih.gov/pubmed/36670100
http://dx.doi.org/10.1038/s41419-022-05548-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9853486/
https://www.ncbi.nlm.nih.gov/pubmed/36670100
http://dx.doi.org/10.1038/s41419-022-05548-4

Ejemplares similares